Surface re-engineering of pancreatic islets with recombinant azido-thrombomodulin

Cherie L. Stabler, Xue Long Sun, Wanxing Cui, John T. Wilson, Carolyn A. Haller, Elliot L. Chaikof

Research output: Contribution to journalArticle

75 Scopus citations

Abstract

Chemoselective conjugation of an azido-functionalized thrombomodulin to pancreatic islets was achieved by Staudinger ligation to a surface-bound bifunctional poly(ethylene glycol) linker. The presence of the tethered thrombomodulin resulted in a significant increase in the production of activated protein C with a reduction in islet-mediated thrombogenicity. This report highlights the potential of tissue-targeted chemistry to reduce donor cell mediated procoagulant and proinflammatory responses.

Original languageEnglish (US)
Pages (from-to)1713-1715
Number of pages3
JournalBioconjugate Chemistry
Volume18
Issue number6
DOIs
StatePublished - Nov 1 2007

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Surface re-engineering of pancreatic islets with recombinant azido-thrombomodulin'. Together they form a unique fingerprint.

  • Cite this

    Stabler, C. L., Sun, X. L., Cui, W., Wilson, J. T., Haller, C. A., & Chaikof, E. L. (2007). Surface re-engineering of pancreatic islets with recombinant azido-thrombomodulin. Bioconjugate Chemistry, 18(6), 1713-1715. https://doi.org/10.1021/bc7002814